Sign In
Buy AIM
$0.254
+0.0186 (+7.91%)
At Close: Jul 31, 2026
Company remains on track for a planned December 2026 evaluation of the clinical trial's primary endpoint Company remains on track for a planned December 2026 evaluation of the clinical trial's primary
Coiled Therapeutics strengthens its scientific bench
04:25am, Monday, 08'th Jun 2026
Coiled Therapeutics (AIM:COIL, OTCQB:COTXF) has strengthened the scientific bench behind its lead cancer drug candidate AO-252, appointing Professor Ozgur Sahin as scientific advisor as the programme
AIM ImmunoTech Inc. (AIM) Discusses Ampligen's Potential Role in Addressing BundiBugyo Ebola Outbreak Transcript
11:41am, Thursday, 04'th Jun 2026
AIM ImmunoTech Inc. (AIM) Discusses Ampligen's Potential Role in Addressing BundiBugyo Ebola Outbreak Transcript
Video segment examines current Ebola outbreak concerns, unmet need surrounding the Bundibugyo strain and Ampligen's previously published antiviral research
The Hour-Long Project We Never Would've Started
01:19pm, Wednesday, 03'rd Jun 2026
By Andrew Rice, Partner and Portfolio Manager We may often come off as skeptical about AI in our newsletter. Our skepticism is primarily centered on the AI capital spend and AI company valuations rath
Final Subject Meets Enrollment Criteria and is Scheduled for Mid-June Treatment, More Than One Month Ahead of Original Target Final Subject Meets Enrollment Criteria and is Scheduled for Mid-June Trea
AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration
08:47am, Wednesday, 27'th May 2026
Previously published Biosafety Level 4 pre-clinical study showed 100% survival with early treatment following infection in a mouse model following lethal doses of Ebola
Creo Medical Group to raise £5.5m and advance partial divestment
02:49am, Friday, 22'nd May 2026
Creo Medical Group PLC (AIM:CREO, FRA:1RC, OTC:CMEOF) announced plans to raise approximately £5.5 million through a placing as the medical device company moves to strengthen its balance sheet while
AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement
03:02pm, Wednesday, 20'th May 2026
OCALA, Fla. , May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company", today announced that it has entered into definitive agreements for a registered direct
AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement
03:02pm, Wednesday, 20'th May 2026
OCALA, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc . (NYSE American: AIM) (“AIM” or the “Company”, today announced that it has entered into definitive agreements for a registere
88 Energy says Augusta-1 exploration well is on track for Q1 2027
02:35am, Wednesday, 20'th May 2026
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) has told investors that its planned Augusta-1 exploration well at South Prudhoe on Alaska's North Slope remains on track for a first-quarter 202
CMMI Institute Completes Pilot for New AI Maturity (AIM) Framework
11:41am, Tuesday, 19'th May 2026
SCHAUMBURG, Ill.--(BUSINESS WIRE)-- #isaca--CMMI Institute, a global leader in helping organizations reduce risk, boost performance, and build capability, is now extending this guidance to artificial
Increase in stockholder equity and note extension strengthen Company's ability to advance pancreatic cancer development strategy Increase in stockholder equity and note extension strengthen Company's
Europa Oil & Gas drops as North Yorkshire refuses planning for potential gas drilling
03:56am, Monday, 18'th May 2026
Europa Oil & Gas (Holdings) Plc (AIM:EOG, FRA:EGN) shares fell 8.3% to 1.33p after North Yorkshire Council refused planning permission for the Cloughton gas appraisal well in North Yorkshire. The AIM-
Sintana Energy raises $11.5m to support exploration plans in Namibia
03:09am, Monday, 18'th May 2026
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) has conditionally raised US$11.5 million to back a busy exploration programme, including drilling on the Chevron-operated Nabba-1 well in
